In this paper, the authors aimed to observe the therapeutic effects of transplantation of microencapsulated Schwann cells in rats with neuropathic pain, as well as to investigate the mechanisms of neuropathic pain mediated by P2X3 receptors in dorsal root ganglia. They employed rats with chronic constriction injury as the model of neuropathic pain. Rats were randomly assigned into four groups: sham group, chronic constriction injury group, chronic constriction injury treated with Schwann cells group, and chronic constriction injury treated with microencapsulated Schwann cells group. They concluded that transplantation of microencapsulated Schwann cells can suppress the neuropathic pain mediated by P2X3 receptors in the dorsal root ganglia.
Overall, the text is a little confusing, and needs several corrections for proper readability.
I could not understand the first sentence of the second paragraph of the Introduction. Please rewrite it.
In the Methods, the authors should make it clearer that some rats received treatment with Schwann cells, whereas others received microencapsulated Schwann cells.
In the Discussion, the authors write that "We have observed that the rats in CCI group had better mental status and better food intake after being conscious...". How did the authors evaluate mental status and food intake?
The text needs careful proofreading by the authors. Some parts are very hard to understand.
